THELMA Therapeutics Co., Ltd. announced a private placement of 14,285,714 common shares at an issue price of KRW 700 per share for gross proceeds of KRW 9,999,999,800 on November 10, 2022. The transaction will include participation from AirQ holdings Inc. The transaction was approved by the board of directors of the company. The securities are issued through third party allotment method. The transaction is expected to close on December 20, 2022. The securities issued are subjected to one year holding period.

On December 12, 2022, the company announced that post-closing of the transaction, the number of common shares issued will increase from 31,696,784 shares to 45,982,498 shares.